Federal Research Institute for Animal Health, Friedrich-Loeffler-Institut, Südufer 10, 17493, Greifswald-Insel Riems, Germany.
Arch Virol. 2010 May;155(5):723-31. doi: 10.1007/s00705-010-0648-6. Epub 2010 Mar 24.
Several reports have previously shown that expression of the foot-and-mouth disease virus (FMDV) capsid precursor protein encoding region P1-2A together with the 3C protease (P1-2A/3C) results in correct processing of the capsid precursor into VP0, VP1 and VP3 and formation of FMDV capsid structures that are able to induce a protective immune response against FMDV challenge after immunization using naked DNA constructs or recombinant viruses. To elucidate whether bovine herpesvirus 1 (BHV-1) might also be suitable as a viral vector for empty capsid generation, we aimed to integrate a P1-2A/3C expression cassette into the BHV-1 genome, which, however, failed repeatedly. In contrast, BHV-1 recombinants that expressed an inactive 3C protease or the P1-2A polyprotein alone could be easily generated, although the recombinant that expressed P1-2A exhibited a defect in direct cell-cell spread and release of infectious particles. These results suggested that expression of the original, active FMDV 3C protease is not compatible with BHV-1 replication. This conclusion is supported by the isolation of recombinant BHV-1/3C*, which contained mutations within the 3C ORF (3C* ORF)--probably introduced spontaneously during generation of BHV-1/3C*--instead of the authentic 3C ORF contained in the transfer plasmids. Within the 3C* ORF, the codons for glycine 38 and phenylalanine 48 were both substituted by codons for serine. The resulting 3C* protease exhibits a highly reduced activity for proteolytic processing of the P1-2A polyprotein and thus might be a good candidate for the generation of live attenuated FMDV variants.
先前有几份报告表明,表达口蹄疫病毒(FMDV)衣壳前体蛋白编码区 P1-2A 与 3C 蛋白酶(P1-2A/3C)一起可导致衣壳前体正确加工成 VP0、VP1 和 VP3,并形成 FMDV 衣壳结构,这些结构能够在使用裸 DNA 构建体或重组病毒进行免疫接种后诱导针对 FMDV 挑战的保护性免疫反应。为了阐明牛疱疹病毒 1(BHV-1)是否也可作为空衣壳产生的病毒载体,我们旨在将 P1-2A/3C 表达盒整合到 BHV-1 基因组中,但反复失败。相比之下,很容易产生表达无活性 3C 蛋白酶或单独 P1-2A 多蛋白的 BHV-1 重组体,尽管表达 P1-2A 的重组体在直接细胞-细胞传播和释放感染性颗粒方面存在缺陷。这些结果表明,表达原始、活性的 FMDV 3C 蛋白酶与 BHV-1 复制不兼容。这一结论得到了重组 BHV-1/3C的分离支持,该重组体包含 3C ORF 内的突变(3CORF)——可能是在生成 BHV-1/3C时自发引入的——而不是转移质粒中包含的真实 3C ORF。在 3CORF 内,甘氨酸 38 和苯丙氨酸 48 的密码子均被丝氨酸的密码子取代。由此产生的 3C*蛋白酶对 P1-2A 多蛋白的蛋白水解加工活性显著降低,因此可能是生成活的减毒 FMDV 变体的良好候选物。